Spikes in Prescription Drugs
The Department of Financial Services investigates significant price increases for certain drugs sold, purchased or advertised in New York State and requires companies to show a reasonable justification for sudden increases. A price hike should be reported when:
- you can show that the price for a prescription drug increased by fifty percent (50%) or more within the last calendar year, and
- that the drug has been sold and is being offered for sale within the state of New York.
Report A Drug Price Spike
Use the DFS Portal to report a dramatic increase in the cost of a drug or pharmacy benefit that you use. You can also check the status of a complaint, or add information to an existing complaint. Be aware that we may share a copy of your complaint with the company or individual you are complaining about.
To get started please visit our secure Portal:
Drugs identified for investigation will be listed here.
- Ascor (ascorbic acid) 25,000 mg/50 mL bulk vial
- Budesonide 0.5 mg/2 mL inhalation (60 mL).
- Dexonto (dexamethasone) 5 mL vial of a 0.4% solution
- Mytesi (crofelemer) 125 mg delayed release tablet, 60s
- Duramorph (morphine sulfate) 1 mg/1 ml (10 mL 10s)
- Chloroquine phosphate 250 mg tablets
The outcomes of previous investigations will be posted to our Reports & Publications section as they are released.
Drug Price Spike Reporting Form in Other Languages
You are strongly encouraged to submit your complaint online using our Secure Portal above. This will avoid delay in the handling of your paper complaint.
Paper complaint forms can be mailed to the Department of Financial Services, Attn: Office of Pharmacy Benefits, 1 Commerce Plaza, Albany, NY 12257.